Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder

British Journal of Psychiatry

Volumn 195, Issue 5, 2009, Pages 393-402

  Radua, Joaquim ^a,b   Mataix Cols, David ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Barcelona Biomedical Research Park   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

BASAL GANGLION; BRAIN MAPPING; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; CINGULATE GYRUS; DISEASE SEVERITY; GRAY MATTER; HUMAN; MORPHOMETRICS; OBSESSIVE COMPULSIVE DISORDER; PUBLICATION; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; BRAIN; BRAIN MAPPING; CHILD; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; OBSESSIVE-COMPULSIVE DISORDER; SENSITIVITY AND SPECIFICITY;

EID: 70450211847     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.108.055046     Document Type: Review

References (65)

1. Robinson D, Wu H, Munne RA, Ashtari M, Alvir JM, Lerner G, et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry 1995; 52: 393-398
2. Aylward EH, Harris GJ, Hoehn-Saric R, Barta PE, Machlin SR, Pearlson GD. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Arch Gen Psychiatry 1996; 53: 577-584 (Pubitemid 26240860)
3. Scarone S, Colombo C, Livian S, Abbruzzese M, Ronchi P, Locatelli M, et al. Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res 1992; 45: 115-121
4. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage 2000; 11: 805-821
5. Ashburner J, Friston KJ. Why voxel-based morphometry should be used. Neuroimage 2001; 14: 1238-1243 (Pubitemid 33124172)
6. Mechelli A, Price CJ, Friston KJ, Ashburner J. Voxel-based morphometry of the human brain: methods and applications. Curr Med Imag Rev 2005; 1: 105-113
7. Mataix-Cols D, Pertusa A, Leckman JF. Issues for DSM-V: how should obsessive-compulsive and related disorders be classified? Am J Psychiatry 2007; 164: 1313-1314
8. Cecconi JP, Lopes AC, Duran FL, Santos LC, Hoexter MQ, Gentil AF, et al. Gamma ventral capsulotomy for treatment of resistant obsessive-compulsive disorder: a structural MRI pilot prospective study. Neurosci Lett 2008; 447: 138-142
9. Cardoner N, Soriano-Mas C, Pujol J, Alonso P, Harrison BJ, Deus J, et al. Brain structural correlates of depressive comorbidity in obsessive-compulsive disorder. Neuroimage 2007; 38: 413-421 (Pubitemid 47554626)
10. Soriano-Mas C, Pujol J, Alonso P, Cardoner N, Menchon JM, Harrison BJ, et al. Identifying patients with obsessive-compulsive disorder using whole-brain anatomy. Neuroimage 2007; 35: 1028-1037 (Pubitemid 46509847)
11. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012
12. Turkeltaub PE, Eden GF, Jones KM, Zeffiro TA. Meta-analysis of the functional neuroanatomy of single-word reading: method and validation. Neuroimage 2002; 16: 765-780
13. Wager TD, Lindquist M, Kaplan L. Meta-analysis of functional neuroimaging data: current and future directions. Soc Cogn Affect Neurosci 2007; 2: 150-158
14. Lancaster JL, Tordesillas-Gutierrez D, Martinez M, Salinas F, Evans A, Zilles K, et al. Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template. Hum Brain Mapp 2007; 28: 1194-1205 (Pubitemid 350077483)
15. Brett M. The MNI brain and the Talairach atlas. Cambridge Imagers, 1999 (http://imaging.mrc-cbu.com.ac.uk/imaging/MniTalairach).
16. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000; 10: 120-131 (Pubitemid 30456920)
17. Salimi-Khorshidi G, Smith SM, Keltner JR, Wager TD, Nichols TE. Meta-analysis of neuroimaging data: a comparison of image-based and coordinate-based pooling of studies. Neuroimage 2008; 45: 810-823
18. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008; 32: 525-549 (Pubitemid 351173336)
19. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870-878 (Pubitemid 34852500)
20. Carmona S, Bassas N, Rovira M, Gispert JD, Soliva JC, Prado M, et al. Pediatric OCD structural brain deficits in conflict monitoring circuits: a voxel-based morphometry study. Neurosci Lett 2007; 421: 218-223 (Pubitemid 46935359)
21. Christian CJ, Lencz T, Robinson DG, Burdick KE, Ashtari M, Malhotra AK, et al. Gray matter structural alterations in obsessive-compulsive disorder: relationship to neuropsychological functions. Psychiatry Res 2008; 164: 123-131
22. Gilbert AR, Mataix-Cols D, Almeida JR, Lawrence N, Nutche J, Diwadkar V, et al. Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study. J Affect Disord 2008; 109: 117-126
23. Gilbert AR, Keshavan MS, Diwadkar v, Nutche J, Macmaster F, Easter PC, et al. Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study. Neurosci Lett 2008; 435: 45-50.
24. Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J, et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61: 720-730 (Pubitemid 38890807)
25. Riffkin J, Yucel M, Maruff P, Wood SJ, Soulsby B, Olver J, et al. A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Res 2005; 138: 99-113. (Pubitemid 40568784)
26. Valente Jr, AA, Miguel EC, Castro CC, Amaro Jr E, Duran FL, Buchpiguel CA, et al. Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol Psychiatry 2005; 58: 479-487 (Pubitemid 41393610)
27. van den Heuvel OA, Remijnse PL, Mataix-Cols D, Vrenken H, Groenewegen HJ, Uylings HB, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain 2009; 132: 853-868
28. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development use, and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011
29. Kim JJ, Lee MC, Kim J, Kim IY, Kim SI, Han MH, et al. Grey matter abnormalities in obsessive-compulsive disorder. Statistical parametric mapping of segmented magnetic resonance images. Br J Psychiatry 2001; 179: 330-334 (Pubitemid 32996042)
30. Szeszko PR, Christian C, Macmaster F, Lencz T, Mirza Y, Taormina SP, et al. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. Am J Psychiatry 2008; 165: 1299-1307
31. Yoo SY, Roh MS, Choi JS, Kang DH, Ha TH, Lee JM, et al. voxel-based morphometry study of gray matter abnormalities in obsessive-compulsive disorder. J Korean Med Sci 2008; 23: 24-30.
32. Rapoport JL, Wise SP. obsessive-compulsive disorder: evidence for basal ganglia dysfunction Psychopharmacol Bull 1988; 34; 380-384
33. Baxter Jr LR, Saxena S, Brody AL, Ackermann RF, Colgan M, Schwartz JM, et al. Brain mediation of obsessive-compulsive disorder symptoms: evidence from functional brain imaging studies in the human and nonhuman primate. Semin Clin Neuropsychiatry 1996; 1: 32-47.
34. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry 1998; 173 (suppl 35): 26-37. (Pubitemid 28368348)
35. Mataix-Cols D, van den Heuvel OA. Common and distinct neural correlates of obsessive-compulsive and related disorders. Psychiatr Clin North Am 2006; 29: 391-410, viii.
36. Swedo SE, Schapiro MB, Grady CL, Cheslow DL. Leonard HL, Kumar A, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989; 46: 518-523 (Pubitemid 19153879)
37. Perani D, Colombo C, Bressl S, Bonfanti A, Grassi F, Scarone S, et al. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry 1995; 166: 244-250
38. Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994; 51: 62-70. (Pubitemid 24028999)
39. Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN, et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53: 595-606. (Pubitemid 26240862)
40. Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61: 564-576 (Pubitemid 38747311)
41. Fitzgerald KD, Welsh RC, Gehring WJ, Abelson JL, Himle JA, Liberzon I, et al. Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biol Psychiatry 2005; 57: 287-294 (Pubitemid 40187373)
42. Ursu S, Stenger VA, Shear MK, Jones MR, Carter CS. Overactive action monitoring in obsessive-compulsive disorder: evidence from functional magnetic resonance imaging. Psychol Sci 2003; 14: 347-353 (Pubitemid 37282832)
43. Yucel M, Harrison BJ, wood SJ, Fornito A, Wellard RM, Pujol J, et al. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Arch Gen Psychiatry 2007; 64: 946-955
44. Maltby N, Tolin DF, Worhunsky P, O'Keefe TM, Kiehl KA. Dysfunctional action monitoring hyperactivates frontal-striatal circuits in obsessive-compulsive disorder: an event-related fMRI study. Neuroimage 2005; 24: 495-503. (Pubitemid 41359045)
45. Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 2005; 29: 399-419.
46. Rauch SL, Dougherty DD, Malone D, Rezai A, Friehs G, Fischman AJ, et al. A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. J Neurosurg 2006; 104: 558-565 (Pubitemid 44607055)
47. Greenberg BD, Gabriels LA, Malone Jr DA, Rezai AR, Friehs GM, Okun MS, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry 2008; May 20 (epub ahead of print).
48. Liu K, Zhang H, Liu C, Guan Y, Lang L, Cheng Y, et al. Stereotactic treatment of refractory obsessive compulsive disorder by bilateral capsulotomy with 3 years follow-up. J Clin Neurosci 2008; 15: 622-629
49. Nuttin BJ, Gabriels LA, Cosyns PR, Meyerson BA, Andreewitch S, Sunaert SG, et al. Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery 2003; 52: 1263-1272 (Pubitemid 36666941)
50. Dougherty DD, Baer L, Cosgrove GR, Cassem EH, Price BH, Nierenberg AA, et al. Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am J Psychiatry 2002; 159: 269-275 (Pubitemid 34126905)
51. Greenspan JD, Coghill RC, Gilron I, Sarlani E, veldhuijzen DS, Lenz FA. Quantitative somatic sensory testing and functional imaging of the response to painful stimuli before and after cingulotomy for obsessive-compulsive disorder (OCD). Eur J Pain 2008; 12: 990-999
52. Kim CH, Chang JW, Koo MS, Kim JW, Suh HS, Park IH, et al. Anterior cingulotomy for refractory obsessive-compulsive disorder. Acta Psychiatr Scand 2003; 107: 283-290 (Pubitemid 36458212)
53. Spangler WJ, Cosgrove GR, Ballantine Jr HT, Cassem EH, Rauch SL, Nierenberg A, et al. Magnetic resonance image-guided stereotactic cingulotomy for intractable psychiatric disease. Neurosurgery 1996; 38: 1071-1076 (Pubitemid 26162750)
54. Ballantine Jr HT, Bouckoms AJ, Thomas EK, Giriunas IE. Treatment of psychiatric illness by stereotactic cingulotomy. Biol Psychiatry 1987; 22: 807-819
55. Kim MC, Lee TK, Choi CR. Review of long-term results of stereotactic psychosurgery. Neurol Med Chir (Tokyo) 2002; 42: 365-371
56. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog Brain Res 1990; 85: 119-146
57. Kunishio K, Haber SN. Primate cingulostriatal projection: limbic striatal versus sensorimotor striatal input. J Comp Neurol 1994; 350: 337-356 (Pubitemid 24356002)
58. Rauch SL, Kim H, Makris N, Cosgrove GR, Cassem EH, Savage CR, et al. Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study. J Neurosurg 2000; 93: 1019-25.
59. Menzies L, Achard S, Chamberlain SR, Fineberg N, Chen CH, del Campo N, et al. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007; 130: 3223-3226
60. Menzies L, Williams GB, Chamberlain SR, Ooi C, Fineberg N, Suckling J, et al. White matter abnormalities in patents with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry 2008; 165: 1308-1315
61. Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, MacMaster FP, et al. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 2000; 57: 449-456 (Pubitemid 30257259)
62. Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000; 39: 1096-1103 (Pubitemid 30676817)
63. Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005; 162: 228-238
64. Saxena S, Brady AL, Maidment KM, Smith EC, Zohrabi N, Katz E, et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 2004; 161: 1038-1048 (Pubitemid 38735990)
65. An SK, Mataix-Cols D, Lawrence NS, Wooderson S, Giampietro V, Speckens A, et al. To discard or not to discard: the neural basis of hoarding symptoms in obsessive-compulsive disorder. Mol Psychiatry 2008; 14: 318-331